Kim EY - Search Results

1

Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015.

Yeo CD, Lee MK, Lee SH, Kim EY, Lee IJ, Park HS, Chang YS. Yeo CD, et al. Among authors: kim ey. Tuberc Respir Dis (Seoul). 2018 Jan;81(1):19-28. doi: 10.4046/trd.2017.0112. Tuberc Respir Dis (Seoul). 2018. PMID: 29332321 Free PMC article. Review.

2

New Targeted Therapy for Non-Small Cell Lung Cancer.

Chung EK, Yong SH, Lee EH, Kim EY, Chang YS, Lee SH. Chung EK, et al. Among authors: kim ey. Tuberc Respir Dis (Seoul). 2023 Jan;86(1):1-13. doi: 10.4046/trd.2022.0066. Epub 2022 Oct 5. Tuberc Respir Dis (Seoul). 2023. PMID: 36196556 Free PMC article.

3

Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer.

Lee SH, Kim EY, Kim T, Chang YS. Lee SH, et al. Among authors: kim ey, kim t. Respir Res. 2020 Jun 9;21(1):142. doi: 10.1186/s12931-020-01408-x. Respir Res. 2020. PMID: 32517757 Free PMC article.

4

Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer.

Kim EY, Jung JY, Kim A, Kim K, Chang YS. Kim EY, et al. Among authors: kim a, kim k. BMC Cancer. 2017 Jul 5;17(1):467. doi: 10.1186/s12885-017-3452-9. BMC Cancer. 2017. PMID: 28679377 Free PMC article.

5

A national survey of lung cancer specialists' views on low-dose CT screening for lung cancer in Korea.

Shin DW, Chun S, Kim YI, Kim SJ, Kim JS, Chong S, Park YS, Song SY, Lee JH, Ahn HK, Kim EY, Yang SH, Lee MK, Cho DG, Jang TW, Son JW, Ryu JS, Cho MJ. Shin DW, et al. Among authors: kim yi, kim ey, kim sj, kim js. PLoS One. 2018 Feb 8;13(2):e0192626. doi: 10.1371/journal.pone.0192626. eCollection 2018. PLoS One. 2018. PMID: 29420619 Free PMC article.

6

Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation.

Lee SH, Kim EY, Kim A, Chang YS. Lee SH, et al. Among authors: kim ey, kim a. Cancer Biol Ther. 2020 Aug 2;21(8):741-748. doi: 10.1080/15384047.2020.1776579. Epub 2020 Jun 16. Cancer Biol Ther. 2020. PMID: 32543264 Free PMC article.

7

Increased number of subclones in lung squamous cell carcinoma elicits overexpression of immune related genes.

Song MJ, Lee SH, Kim EY, Chang YS. Song MJ, et al. Among authors: kim ey. Transl Lung Cancer Res. 2020 Jun;9(3):659-669. doi: 10.21037/tlcr-19-589. Transl Lung Cancer Res. 2020. PMID: 32676328 Free PMC article.

8

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer.

Lee JH, Kim EY, Park CK, Lee SY, Lee MK, Yoon SH, Lee JE, Lee SH, Kim SJ, Lee SY, Lim JH, Jang TW, Jang SH, Lee KY, Lee SH, Yang SH, Park DW, Park CK, Kang HS, Yeo CD, Choi CM, Lee JC. Lee JH, et al. Among authors: kim ey, kim sj. Cancer Res Treat. 2023 Jan;55(1):112-122. doi: 10.4143/crt.2022.381. Epub 2022 Jul 19. Cancer Res Treat. 2023. PMID: 36049499 Free PMC article.

9

Prediction model for hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitors.

Choi YJ, Kim T, Kim EY, Lee SH, Kwon DS, Chang YS. Choi YJ, et al. Among authors: kim ey, kim t. Thorac Cancer. 2020 Oct;11(10):2793-2803. doi: 10.1111/1759-7714.13594. Epub 2020 Aug 11. Thorac Cancer. 2020. PMID: 32779394 Free PMC article.

10

Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation.

Kim EY, Lee SH, Kim A, Kim T, Chang YS. Kim EY, et al. Among authors: kim a, kim t. J Cancer. 2019 Aug 29;10(22):5549-5556. doi: 10.7150/jca.32897. eCollection 2019. J Cancer. 2019. PMID: 31632498 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,023 results

Search Page